Search Results - "Thomas Rozario"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Whole chromosome loss and associated breakage–fusion–bridge cycles transform mouse tetraploid cells by Thomas, Rozario, Marks, Daniel Henry, Chin, Yvette, Benezra, Robert

    Published in The EMBO journal (17-01-2018)
    “…Whole chromosome gains or losses (aneuploidy) are a hallmark of ~70% of human tumors. Modeling the consequences of aneuploidy has relied on perturbing spindle…”
    Get full text
    Journal Article
  2. 2

    Integrated analysis of patient samples identifies biomarkers for venetoclax efficacy and combination strategies in acute myeloid leukemia by Zhang, Haijiao, Nakauchi, Yusuke, Köhnke, Thomas, Stafford, Melissa, Bottomly, Daniel, Thomas, Rozario, Wilmot, Beth, McWeeney, Shannon K, Majeti, Ravindra, Tyner, Jeffrey W

    Published in Nature cancer (01-08-2020)
    “…Deregulation of the gene family plays an important role in the pathogenesis of acute myeloid leukemia (AML). The BCL2 inhibitor, venetoclax, has received FDA…”
    Get full text
    Journal Article
  3. 3

    Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target by Cook, Peter J., Thomas, Rozario, Kannan, Ram, de Leon, Esther Sanchez, Drilon, Alexander, Rosenblum, Marc K., Scaltriti, Maurizio, Benezra, Robert, Ventura, Andrea

    Published in Nature communications (11-07-2017)
    “…The widespread application of high-throughput sequencing methods is resulting in the identification of a rapidly growing number of novel gene fusions caused by…”
    Get full text
    Journal Article
  4. 4

    Mad2 Overexpression Uncovers a Critical Role for TRIP13 in Mitotic Exit by Marks, Daniel Henry, Thomas, Rozario, Chin, Yvette, Shah, Riddhi, Khoo, Christine, Benezra, Robert

    Published in Cell reports (Cambridge) (30-05-2017)
    “…The mitotic checkpoint ensures proper segregation of chromosomes by delaying anaphase until all kinetochores are bound to microtubules. This inhibitory signal…”
    Get full text
    Journal Article
  5. 5

    Correction: Author Correction: Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target by Cook, Peter J., Thomas, Rozario, Kannan, Ram, de Leon, Esther Sanchez, Drilon, Alexander, Rosenblum, Marc K., Scaltriti, Maurizio, Benezra, Robert, Ventura, Andrea

    Published in Nature communications (13-03-2018)
    “…Nature Communications 8: Article number: 15987 (2017); Published: 11 July 2017; Updated: 13 March 2018 In the original version of this Article, financial…”
    Get full text
    Journal Article
  6. 6

    Integrated Hydrological Model-Based Assessment of Stormwater Management Scenarios in Copenhagen’s First Climate Resilient Neighbourhood Using the Three Point Approach by Sara Maria Lerer, Francesco Righetti, Thomas Rozario, Peter Steen Mikkelsen

    Published in Water (Basel) (01-11-2017)
    “…The city of Copenhagen currently pursues a very ambitious plan to make the city ‘cloudburst proof’ within the next 30 years. The cloudburst management plan has…”
    Get full text
    Journal Article
  7. 7

    No Matter How You Splice It, RBM39 Inhibition Targets Spliceosome Mutant AML by Thomas, Rozario, Majeti, Ravindra

    Published in Cancer cell (18-03-2019)
    “…A report in this issue of Cancer Cell identifies the RNA-binding protein RBM39 as a potential target in spliceosome mutant AML that can be targeted by existing…”
    Get full text
    Journal Article
  8. 8

    Cox-2-derived PGE2 induces Id1-dependent radiation resistance and self-renewal in experimental glioblastoma by Cook, Peter J, Thomas, Rozario, Kingsley, Philip J, Shimizu, Fumiko, Montrose, David C, Marnett, Lawrence J, Tabar, Viviane S, Dannenberg, Andrew J, Benezra, Robert

    Published in Neuro-oncology (Charlottesville, Va.) (01-10-2016)
    “…In glioblastoma (GBM), Id1 serves as a functional marker for self-renewing cancer stem-like cells. We investigated the mechanism by which cyclooxygenase-2…”
    Get full text
    Journal Article
  9. 9

    Whole Chromosome Loss Events in a Tetraploid Background Confer Tumorigenic Potential in a Mouse Allograft Model by Thomas, Rozario

    Published 2018
    “…Aneuploidy is a hallmark of most human tumors and is a poor prognostic marker. Mouse models of aneuploidy rely on altering the levels of proteins involved in…”
    Get full text
    Dissertation
  10. 10
  11. 11